Strs Ohio decreased its position in shares of Encompass Health Corporation (NYSE:EHC – Free Report) by 67.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 39,950 shares of the company’s stock after selling 81,640 shares during the quarter. Strs Ohio’s holdings in Encompass Health were worth $3,864,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently bought and sold shares of the company. WPG Advisers LLC grew its stake in shares of Encompass Health by 73.3% in the 4th quarter. WPG Advisers LLC now owns 324 shares of the company’s stock valued at $34,000 after buying an additional 137 shares during the period. Flagship Harbor Advisors LLC acquired a new stake in Encompass Health during the fourth quarter worth $37,000. Caitong International Asset Management Co. Ltd raised its position in Encompass Health by 36,200.0% in the third quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock valued at $46,000 after purchasing an additional 362 shares during the period. Aster Capital Management DIFC Ltd acquired a new stake in shares of Encompass Health during the 4th quarter worth about $55,000. Finally, Covestor Ltd lifted its position in Encompass Health by 24.4% in the fourth quarter. Covestor Ltd now owns 540 shares of the company’s stock valued at $57,000 after buying an additional 106 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.
Encompass Health Stock Performance
EHC traded up $2.94 during trading on Tuesday, hitting $109.93. 24,983 shares of the stock were exchanged, compared to its average volume of 1,098,868. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.76. The firm has a market capitalization of $10.91 billion, a P/E ratio of 18.31, a PEG ratio of 2.32 and a beta of 0.74. The stock has a fifty day moving average price of $103.20 and a two-hundred day moving average price of $103.39. Encompass Health Corporation has a 1-year low of $92.77 and a 1-year high of $127.99.
Encompass Health Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a $0.19 dividend. The ex-dividend date is Wednesday, July 1st. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is presently 12.69%.
Analyst Upgrades and Downgrades
A number of research analysts have commented on the company. Leerink Partners set a $152.00 price target on Encompass Health in a research note on Friday, May 22nd. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Weiss Ratings lowered Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, June 26th. Barclays lowered their price objective on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a research report on Tuesday, May 5th. Finally, TD Cowen began coverage on shares of Encompass Health in a research report on Thursday, May 28th. They issued a “buy” rating and a $125.00 price objective on the stock. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, Encompass Health presently has an average rating of “Moderate Buy” and an average target price of $143.86.
Get Our Latest Stock Report on Encompass Health
Insider Activity
In related news, EVP Patrick William Tuer sold 682 shares of Encompass Health stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the sale, the executive vice president directly owned 24,755 shares in the company, valued at $2,588,382.80. The trade was a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.80% of the company’s stock.
About Encompass Health
Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.
Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.
Featured Stories
- Five stocks we like better than Encompass Health
- GE Vernova’s Power Surge Turns the Grid Into an AI Trade
- Orbiting Capital: Lawmakers Buy SpaceX Ahead of Index Inclusion
- Big Beautiful Boycott: Can It Really Hurt Coca-Cola, Amazon, and Kraft Heinz Stocks?
- 3 Stocks With Solid Yields and Sustainabale Payouts Boost Dividends Once Again
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC – Free Report).
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.
